Crosswalk Therapeutics, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 10
Rang # Quantité totale PI 153 342
Note d'activité PI 1,9/5.0    11
Rang # Activité PI 81 230

Brevets

Marques
9 0
0 0
1 0
0
 
Dernier brevet 2025 - Engineered acid alpha-glucosidas...
Premier brevet 2015 - Human alpha-galactosidase variants

Derniers inventions, produits et services

2024 Invention Engineered acid alpha-glucosidase variants. The present disclosure provides engineered acid alpha...
Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha...
2022 Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galact...
2020 Invention Engineered acid alpha-glucosidase variants. The present invention provides engineered acid alpha-...
Invention Human alpha-galactosidase variants. The present invention provides engineered human alpha-galacto...